申请人:Moffat David Festus Charles
公开号:US20100087515A1
公开(公告)日:2010-04-08
Compounds of formula (IA) or (IB) are inhibitors of IkB kinase (IKK) activity, and are useful in the treatment of autoimmune and inflammatory diseases: Formula (A) and (B) wherein R
7
is hydrogen or optionally substituted (C
1
-C
6
)alkyl; ring A is an optionally substituted aryl or heteroaryl ring of 5-13 ring atoms; Z is (a) a radical of formula R
1
R
2
CHNH—Y-L
1
-X
1
—(CH
2
)
z
— wherein: z is 0 or 1; R1 is a carboxylic acid group (—COOH), or an ester group which is hydrolysable by one or more intracellular esterase enzymes to a carboxylic acid group; R2 is the side chain of a natural or non-natural alpha amino acid; Y is a bond, —C(═O)—, —S(═P)2-, —C(═O)O—, —C(═O)NR3-, —C(═S)—NR
3
, —C(═NH)—NR
3
or —S(═O)
2
NR
3
— wherein R
3
is hydrogen or optionally substituted C
1
-C
6
alkyl; L is a divalent linker radical of formula -(Alk
1
)
m
(Q)(Alk
2
)
p
- wherein m, n, p, Q, AIk
1
and AIk
2
are as defined in the claims.
公式(IA)或(IB)的化合物是IkB激酶(IKK)活性的抑制剂,并且在治疗自身免疫和炎症性疾病方面是有用的:公式(A)和(B)其中R7是氢或可选取代的(C1-C6)烷基; 环A是5-13个环原子的可选取代芳基或杂环芳基环; Z是公式R1R2CHNH-Y-L1-X1(CH2)z的基团,其中:z为0或1; R1是羧酸基(-COOH)或一个酯基,该酯基可被一个或多个细胞内酯酶酶水解为羧酸基; R2是天然或非天然α氨基酸的侧链; Y是键,-C(=O)-,-S(=P)2-,-C(=O)O-,-C(=O)NR3-,-C(=S)-NR3,-C(=NH)-NR3或-S(=O)2NR3-,其中R3是氢或可选取代的C1-C6烷基; L是公式-(Alk1)m(Q)(Alk2)p-的二价连接基团,其中m,n,p,Q,Alk1和Alk2如权利要求所定义。